LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
10.64
+0.06 (0.57%)
At close: May 20, 2025, 4:00 PM
10.62
-0.02 (-0.19%)
Pre-market: May 21, 2025, 5:43 AM EDT
LifeMD Market Cap
LifeMD has a market cap or net worth of $483.56 million as of May 21, 2025. Its market cap has decreased by -4.09% in one year.
Market Cap
483.56M
Enterprise Value
474.27M
1-Year Change
-4.09%
Ranking
Category
Stock Price
$10.64
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $483.56M, an increase of 13,716.07%. That is a compound annual growth rate of 50.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 480.80M | 124.25% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |